Gilead, LEO Pharma partner to develop programs for inflammatory diseases By Reuters
(Reuters) - Gilead Sciences (NASDAQ:) said on Saturday that it entered into a partnership with Denmark's LEO Pharma to develop...
(Reuters) - Gilead Sciences (NASDAQ:) said on Saturday that it entered into a partnership with Denmark's LEO Pharma to develop...
After-hours movers: NVIDIA (NASDAQ:) fell 1.4% after Bloomberg reported that Biden will further curb AI chip exports in a final...